ES8608886A1 - Procedimiento de preparar un antigeno relacionado con el ligamento glicosidico,derivado de celulas de cancer. - Google Patents

Procedimiento de preparar un antigeno relacionado con el ligamento glicosidico,derivado de celulas de cancer.

Info

Publication number
ES8608886A1
ES8608886A1 ES542835A ES542835A ES8608886A1 ES 8608886 A1 ES8608886 A1 ES 8608886A1 ES 542835 A ES542835 A ES 542835A ES 542835 A ES542835 A ES 542835A ES 8608886 A1 ES8608886 A1 ES 8608886A1
Authority
ES
Spain
Prior art keywords
tca
related antigen
preparing
glycosidic linkage
producing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES542835A
Other languages
English (en)
Other versions
ES542835A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Publication of ES8608886A1 publication Critical patent/ES8608886A1/es
Publication of ES542835A0 publication Critical patent/ES542835A0/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/00119—Melanoma antigens
    • A61K39/001192—Glycoprotein 100 [Gp100]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/828—Cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Manufacture, Treatment Of Glass Fibers (AREA)

Abstract

PROCEDIMIENTO DE PREPARACION DE UN ANTIGENO RELACIONADO CON EL LIGAMENTO GLICOSIDO, DERIVADO DE CELULAS DE CANCER (GRA). CONSISTE EN TRATAR UN COMPONENTE DE LA MEMBRANA CELULAR DE CELULA DE CANCER HUMANO CON UNA SUSTANCIA CAPAZ DE FORMAR UN ENLACE CON UNA ESTRUCTURA DE LIGAMENTO GLICOSIDICO DE FUCOSA TERMINAL TAL COMO LA LECITINA O UN ANTICUERPO. APLICABLE POR SU ACCION INMUNOGENA EN LA TERAPIA Y PROFILAXIS DEL CANCER.
ES542835A 1984-04-06 1985-04-04 Procedimiento de preparar un antigeno relacionado con el ligamento glicosidico,derivado de celulas de cancer. Expired ES8608886A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59068668A JPS60214737A (ja) 1984-04-06 1984-04-06 糖鎖関連抗原の製造法

Publications (2)

Publication Number Publication Date
ES8608886A1 true ES8608886A1 (es) 1986-09-16
ES542835A0 ES542835A0 (es) 1986-09-16

Family

ID=13380318

Family Applications (2)

Application Number Title Priority Date Filing Date
ES542835A Expired ES8608886A1 (es) 1984-04-06 1985-04-04 Procedimiento de preparar un antigeno relacionado con el ligamento glicosidico,derivado de celulas de cancer.
ES551356A Expired ES8706447A1 (es) 1984-04-06 1986-01-29 Procedimiento de preparar un antigeno relacionado con el ligamiento glicosidico derivado de celulas de cancer

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES551356A Expired ES8706447A1 (es) 1984-04-06 1986-01-29 Procedimiento de preparar un antigeno relacionado con el ligamiento glicosidico derivado de celulas de cancer

Country Status (13)

Country Link
US (1) US4849510A (es)
EP (1) EP0157427A3 (es)
JP (1) JPS60214737A (es)
KR (1) KR870001375B1 (es)
AU (1) AU593210B2 (es)
CA (2) CA1243607A (es)
DK (1) DK147885A (es)
ES (2) ES8608886A1 (es)
FI (1) FI851373L (es)
NO (1) NO165945C (es)
PH (1) PH21133A (es)
PT (1) PT80233B (es)
ZA (1) ZA852491B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE94395T1 (de) * 1986-05-09 1993-10-15 Pulverer Gerhard Verwendung von spezifischen monosacchariden zur herstellung eines arzneimittels zur verhinderung von metastasen maligner tumore.
JPS62273919A (ja) * 1986-05-21 1987-11-28 Takahiro Ochi 抗リウマチ剤
JPH083487B2 (ja) * 1987-07-31 1996-01-17 株式会社日本抗体研究所 異常応答リンパ球の検出方法並びにこれに用いる検出用試薬及びキット
JPH03263401A (ja) * 1990-03-13 1991-11-22 Nippon Koutai Kenkyusho:Kk 新規糖鎖
MD838G2 (ro) * 1992-07-21 1998-09-30 Alexandr Nicolaenco Remediu biologic activ cu proprietate imunomodulatoare, procedeu de obţinere a lui, preparat pe baza lui şi procedeu de normalizare a stării fiziologice a omului şi animalelor
DE19806185C2 (de) * 1998-02-02 1999-11-18 Biogenes Gmbh Immunoassay und Testkit zur Bestimmung von fucosyliertem Protein in einer biologischen Probe
TWI337868B (en) * 2004-05-21 2011-03-01 Tzu Chi Buddhist General Hospital Method for extracting extract from chaenomeles lagenaria and the applications thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3867363A (en) * 1970-06-01 1975-02-18 Hans John Hansen Carcinoembryonic antigens
US4211766A (en) * 1972-07-10 1980-07-08 Ab Bonnierforetagen Cancer associated polypeptide antigen compositions
US4152410A (en) * 1975-09-03 1979-05-01 Eisai Co., Ltd. Diagnosis reagent for neoplasm and method for diagnosis of neoplasm
GB1598811A (en) * 1977-01-12 1981-09-23 Hoffmann La Roche Carcinoma-associated antigens
US4146603A (en) * 1977-02-18 1979-03-27 Research Corporation Tumor specific glycoproteins and method for detecting tumorigenic cancers
ES8102679A1 (es) * 1979-01-30 1981-02-16 Otsuka Pharma Co Ltd Metodo de analizar fluidos corporales.
US4334017A (en) * 1979-04-16 1982-06-08 Massachusetts Institute Of Technology Method for detecting cancer in mammalian tissue
GB2106935B (en) * 1981-10-01 1985-01-30 Otsuka Pharma Co Ltd Cancer cell-combatting lymphocytes process for the production thereof and anticancer agents containing said lymphocytes
FI77157C (fi) * 1981-10-01 1989-02-10 Otsuka Pharma Co Ltd Foerfarande foer framstaellning av glykobunden antigen och foerfarande foer framstaellning av foer kancerceller toxiska lymfocyter, som aer specifika mot denna antigen.
US4455380A (en) * 1982-01-29 1984-06-19 Otsuka Pharmaceutical Co., Ltd. Process for determining tumor-associated glycolinkage
CA1236016A (en) * 1982-10-08 1988-05-03 Masakazu Adachi Glycosidic linkage related antigen, process for producing the same and anticancer agent containing the same as effective component
AU556941B2 (en) * 1982-10-08 1986-11-27 Otsuka Pharmaceutical Co., Ltd. Glycosidic linkage related antigen

Also Published As

Publication number Publication date
FI851373A0 (fi) 1985-04-04
KR870001375B1 (ko) 1987-07-24
NO851386L (no) 1985-10-07
NO165945B (no) 1991-01-28
FI851373L (fi) 1985-10-07
CA1243607A (en) 1988-10-25
DK147885A (da) 1985-10-07
NO165945C (no) 1991-05-08
CA1240214A (en) 1988-08-09
ES8706447A1 (es) 1987-07-01
AU4081085A (en) 1985-10-10
EP0157427A3 (en) 1987-08-12
PH21133A (en) 1987-07-27
KR850007431A (ko) 1985-12-04
EP0157427A2 (en) 1985-10-09
ES551356A0 (es) 1987-07-01
AU593210B2 (en) 1990-02-08
US4849510A (en) 1989-07-18
DK147885D0 (da) 1985-04-01
JPS60214737A (ja) 1985-10-28
PT80233A (en) 1985-05-01
PT80233B (en) 1987-03-16
ES542835A0 (es) 1986-09-16
ZA852491B (en) 1985-11-27

Similar Documents

Publication Publication Date Title
ES8405071A1 (es) Un procedimiento de preparacion de conjugados inmunoenzimaticos.
DE3174705D1 (en) Synthesis of tumor antigenic determinant
CA2069428A1 (en) A mammalian cytokine, il-11
HUT49363A (en) Process for producing 1,2-bis-(aminomethyl)-cyclobutane-platinum complexes and pharmaceutical compositions comprising same
ES2033871T3 (es) Un procedimiento para producir una preparacion de insulina para administracion parenteral.
MY100952A (en) Immune response to tumours and viruses induced by anti- idiotype antibodies
YU194888A (en) Process for preparing polyorganosyloxanic substances
ES8706447A1 (es) Procedimiento de preparar un antigeno relacionado con el ligamiento glicosidico derivado de celulas de cancer
CA1021629A (en) Process for producing fruit flakes or wafers, and fruit flakes or wafers produced in accordance therewith
JPS5344613A (en) Tumor vaccine containing lectin/tumor cell-complex
MY103665A (en) Anthracycline glycosides
CA1015754A (en) Furo-(2,3d) pyrimidines, preparation process and therapeutic applications thereof
IT1120950B (it) Procedimento per produrre terzi butanolo da butileni misti
IL79260A (en) Process and composition for activation of immune response cells to be used in the treatment of cancer,non-malignant tumors,infections,and immune deficiencies
DE3264718D1 (en) Piperazinoquinazoline antihypertensives, processes for preparing them, pharmaceutical compositions containing them, and immunogenic protein conjugates formed from them
Brown Some Implications for Peacemaking in Apocalyptic Times
IL66270A (en) Cancer cell-derived glyco-related antigen,its production and anticancer agent containing it
Welsh et al. New species of Hymenoxys and Perityle (Compositae) from Utah
Korb et al. The Diffusion of Power
Kugelman Presenting Mary to Today's Catholics
Fendall Theology and Bloodless Revolution
Torve et al. Proposed Final Decree by State of Washington, Department of Natural Resources
Jongsma Responsible Technology: The Challenge of Our Age
Aravena 1985: Año del Impasse de Contadora (Dialogue# 63)
Pye Living in the Life and Sharing It